Transcription News and Research

RSS

Medical Transcription Industry Association to change name to Clinical Documentation Industry Association

Providing innovative solutions for EHR adoption that facilitate accurate and timely capture of health information continues to be a key message for the Medical Transcription Industry Association, whose members recently voted to change its name to Clinical Documentation Industry Association (CDIA) in an effort to reflect not only the expanded scope of services its members provide to the healthcare industry, but also a more appropriate focus on the health record and its critical role in clinical decision-making and continuity of care.

18 Aug 2010

Research shows mutation in Prox1 gene may lead to memory, learning problems

St. Jude Children's Research Hospital investigators showed a gene named Prox1 is a key player in normal development of a brain structure crucial for learning and memory and remains active throughout life, nurturing the cells vital for making new memories.This study focused on a small region of the hippocampus known as the dentate gyrus, a brain structure needed for memory and learning that is home to the subgranular zone where the neural stem cells destined to become granule cells are housed. The dentate gyrus is one of two regions of the adult brain where neural stem cells continue to produce the precursor cells that ultimately differentiate into neurons.

18 Aug 2010

Advanced Cell Technology to obtain patent for cellular reprogramming, generation of iPS cells

Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.

18 Aug 2010

Human adult stem cells can regenerate damaged heart tissue: Research

Mayo Clinic investigators, with Belgian collaborators, have demonstrated that rationally "guided" human adult stem cells can effectively heal, repair and regenerate damaged heart tissue. The findings called "landmark work" in an accompanying editorial appear in today's Journal of the American College of Cardiology.

17 Aug 2010

Researchers find link between chronic inflammation and cancer

Virginia Commonwealth University Massey Cancer Center researchers have uncovered a new link between chronic inflammation and cancer. Although cancers do not always cause inflammation, chronic inflammation is known to help tumor cells grow.

17 Aug 2010

MedQuist second-quarter net revenues increase 25.9% to $97.5 million

MedQuist Inc., a leading provider of medical transcription services and in the technology-enabled clinical documentation workflow, announced its financial results for the second quarter ended June 30, 2010.

12 Aug 2010

GoTaq 2-Step RT-qPCR System allows researchers to detect target genes

The new Promega GoTaq 2-Step RT-qPCR System allows researchers to detect target genes expressed at low levels even with hard-to-amplify samples. Enhanced sensitivity of the two-step system extends the broad dynamic range of RNA quantitation and provides a robust, gene expression analysis tool.

11 Aug 2010

iMedX acquires MedTech Transcriptions

iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of MedTech Transcriptions Inc., a medical transcription company serving medical clinics in Louisiana for over 15 years. With the acquisition of MedTech, iMedX extends its customer base into Louisiana. MedTech's production and customer service teams will augment iMedX's staff to continue to provide superior services to clients across the United States.

11 Aug 2010

MedQuist contributes to new industry standard measurement policy for transcription jobs

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, continues to support industry best practices for quality standards and metrics. Together with the American Health Information Management Association (AHIMA), the Association for Healthcare Documentation Integrity (AHDI), the Medical Transcription Industry Association (MTIA) and other industry quality leaders, MedQuist contributed to the new Healthcare Documentation Quality Assessment and Management Best Practices just unveiled at the AHDI 32nd Annual Convention and Expo.

7 Aug 2010

UCSF researchers discover new technology purifying special types of stem cells

UCSF researchers are reporting the first success in very rapidly purifying one type of embryonic stem cell from a mix of many different types of embryonic stem cells in the culture dish. The technique, which avoids the need to genetically alter the cells to distinguish them, is a key advance, the researchers say, for obtaining the appropriate cells for repairing specific damaged tissues.

7 Aug 2010

Scientists identify role of PNPASE in regulating RNA import into mitochondria

Researchers at UCLA's Jonsson Comprehensive Cancer Center and the departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine have uncovered a role for an essential cell protein in shuttling RNA into the mitochondria, the energy-producing "power plant" of the cell. The import of nucleus-encoded small RNAs into mitochondria is essential for the replication, transcription and translation of the mitochondrial genome, but the mechanisms that deliver RNA into mitochondria remain poorly understood.

7 Aug 2010

Alnylam publishes research findings of Sort1 gene role in cardiovascular disease development

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.

6 Aug 2010

Scientists find molecular cocktail to transform non-muscle cells into cardiac muscle

In heart disease, cardiac muscle gradually dies off and, with little or no way to regenerate those cells, that can ultimately lead the heart to fail. But scientists reporting in the August 6th issue of Cell, a Cell Press publication, might have found a way to fix those losses. They've devised a three-ingredient molecular cocktail that transforms fibroblasts - structural cells that the heart is chock full of - directly into beating heart cells.

6 Aug 2010

SORT1 pathway holds promise as new target for therapeutic intervention for LDL cholesterol reduction

The true power of genomic research lies in its ability to help scientists understand biological processes, particularly those that - when altered - can lead to disease. This power is demonstrated dramatically in a pair of papers published today in the journal Nature. In the first, a global team of researchers describes 95 different variations across the genome that contribute in different degrees to alterations in blood cholesterol and triglyceride levels in multiple human populations. In the second report, close examination of just one of these common variants not only reveals the involvement of an unexpected genetic pathway in lipid metabolism but also provides a blueprint for using genomic findings to unravel biological connections between lipid levels and coronary heart disease.

5 Aug 2010

Research findings show normal rise and fall in triglycerides

When the circadian rhythm gets thrown off, it could come with an unexpected side effect: high triglycerides. The discovery, based on studies in mice with a "broken clock," helps to explain the normal rise and fall in triglycerides, which happens at about the same time each day, according to researchers who report their findings in the August issue of Cell Metabolism, a Cell Press publication.

4 Aug 2010

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4, is essential to healthy heart development and embryonic survival.

2 Aug 2010

Researchers discover mechanism linking H. pylori infection and stomach cancer

Researchers have discovered a mechanism by which Helicobacter pylori, the only known cancer-causing bacterium, disables a tumor suppressor protein in host cells.The new study, in the journal Oncogene, reports the discovery of a previously unknown mechanism linking H. pylori infection and stomach cancer, the second leading cause of cancer deaths worldwide.

2 Aug 2010

microRNA protects red blood cells from oxidant stress: Study

Pediatric researchers have discovered a new biological pathway in which small segments of RNA, called microRNA, help protect red blood cells from injury caused by chemicals called free radicals. The microRNA seems to have only a modest role when red blood cells experience normal conditions, but steps into action when the cells are threatened by oxidant stress.

2 Aug 2010

Nightingale Informatix reports $4.2 million revenue for fourth-quarter fiscal 2010

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and year ended March 31, 2010.

31 Jul 2010

Researchers discover tumor suppressor lincRNAs

The recent discovery of more than a thousand genes known as large intergenic non-coding RNAs (or "lincRNAs") opened up a new approach to understanding the function and organization of the genome. That surprising breakthrough is now made even more compelling with the finding that dozens of these lincRNAs are induced by p53 (the most commonly mutated gene in cancer), suggesting that this class of genes plays a critical role in cell development and regulation. Furthermore, the researchers identify one lincRNA in particular (lincRNA-p21), and demonstrate its critical role in suppressing the reading of many genes across the genome following p53 activation.

30 Jul 2010

Transcription News and Research

Medical Transcription Industry Association to change name to Clinical Documentation Industry Association

Research shows mutation in Prox1 gene may lead to memory, learning problems

Advanced Cell Technology to obtain patent for cellular reprogramming, generation of iPS cells

Human adult stem cells can regenerate damaged heart tissue: Research

Researchers find link between chronic inflammation and cancer

MedQuist second-quarter net revenues increase 25.9% to $97.5 million

GoTaq 2-Step RT-qPCR System allows researchers to detect target genes

iMedX acquires MedTech Transcriptions

MedQuist contributes to new industry standard measurement policy for transcription jobs

UCSF researchers discover new technology purifying special types of stem cells

Scientists identify role of PNPASE in regulating RNA import into mitochondria

Alnylam publishes research findings of Sort1 gene role in cardiovascular disease development

Scientists find molecular cocktail to transform non-muscle cells into cardiac muscle

SORT1 pathway holds promise as new target for therapeutic intervention for LDL cholesterol reduction

Research findings show normal rise and fall in triglycerides

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

Researchers discover mechanism linking H. pylori infection and stomach cancer

microRNA protects red blood cells from oxidant stress: Study

Nightingale Informatix reports $4.2 million revenue for fourth-quarter fiscal 2010

Researchers discover tumor suppressor lincRNAs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News